10 May 2026
·
0 Comments
Explore why generic drugs often seem less effective than brand names despite being scientifically identical. Learn about the nocebo effect, FDA bioequivalence standards, and how to navigate medication switches confidently.
Read more
9 January 2026
·
10 Comments
Clinical studies show generic drugs are just as effective as brand-name drugs for most conditions. Learn what the data says about bioequivalence, safety, and real-world outcomes for providers.
Read more
28 November 2025
·
13 Comments
Replicate study designs are essential for bioequivalence assessment of highly variable drugs, reducing sample sizes by up to 75% while maintaining statistical rigor. Learn how RSABE works, which design to choose, and common pitfalls to avoid.
Read more